THE BOARD OF DIRECTORS OF FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A. TODAY APPROVED THE GROUP'S INTERIM FINANCIAL REPORT AS OF 30 SEPTEMBER 2024. ADJUSTED EBITDA OF € 23.4 MILLION (+27.8%)